Pain News and Research RSS Feed - Pain News and Research

Better quality of care may reduce mortality risk in patients treated with opioid therapy for pain

Better quality of care may reduce mortality risk in patients treated with opioid therapy for pain

Better quality of care may reduce the risk of death for patients who are prescribed opioid painkillers for chronic pain, say Yale researchers. Their study, published Feb. 4 in the Journal of General Internal Medicine, offers evidence that supports recommendations from clinical practice guidelines encouraging physicians to engage patients with mental health services and substance abuse treatment, as well as to avoid co-prescriptions for sedatives. [More]
Discovery takes researchers one step closer to preventing C. diff

Discovery takes researchers one step closer to preventing C. diff

Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital. [More]
Meditation reduces anxiety, pain and fatigue in women undergoing breast cancer biopsies

Meditation reduces anxiety, pain and fatigue in women undergoing breast cancer biopsies

Meditation eases anxiety, fatigue and pain for women undergoing breast cancer biopsies, according to researchers at the Duke Cancer Institute. They also found that music is effective, but to a lesser extent. [More]
Noninvasive FMRI may help evaluate effectiveness of new pain medications

Noninvasive FMRI may help evaluate effectiveness of new pain medications

New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies. [More]
Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according to a new study published by University of Toronto researchers. [More]
NICE recommends Xofigo (radium-223 dichloride) for prostate cancer patients after treatment with docetaxel

NICE recommends Xofigo (radium-223 dichloride) for prostate cancer patients after treatment with docetaxel

The National Institute for Health and Care Excellence has issued its final guidance recommending Xofigo for use on the NHS in England and Wales as an option for treating adult men, with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases, who have received previous docetaxel therapy. [More]
American Diabetes Association issues statement to address diabetes management in LTC facilities

American Diabetes Association issues statement to address diabetes management in LTC facilities

The care of adults over age 65 with type 2 diabetes is a growing concern: the prevalence of diabetes is highest in this age group and is expected to grow as the U.S. population ages, with many needing care at long-term care (LTC) facilities. [More]
Innovative mattresses to stop pressure ulcers: an interview with Mike Hutson

Innovative mattresses to stop pressure ulcers: an interview with Mike Hutson

Pressure ulcers are wounds that occur when a continuous pressure or friction is placed on one area of the body, damaging the skin. They occur when pressure stops blood from flowing normally, leading the cells to die and the skin to break down. [More]
FDA approves ZEMBRACESymTouch (sumatriptan succinate) injection for treatment of acute migraines

FDA approves ZEMBRACESymTouch (sumatriptan succinate) injection for treatment of acute migraines

Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens. [More]
Researchers use new method to assess quality of colonoscopies performed in outpatient facilities

Researchers use new method to assess quality of colonoscopies performed in outpatient facilities

Colonoscopies are now a routine preventive diagnostic test for millions of Americans each year. While rates are low, complications like perforation, bleeding, and anesthesia-related heart failure can occur. Yale School of Medicine researchers have now developed a quality measure that uses follow-up hospital visits to track the variation in colonoscopy quality among outpatient facilities. [More]
CellSonic treatments reduce problems of muscles recovering after exertion

CellSonic treatments reduce problems of muscles recovering after exertion

Since non-invasive shockwaves were used forty years ago to remove kidney stones and became standard procedure in all hospitals worldwide for having no side effects, they have been used in many other applications. [More]
Alternative splicing: a new approach to drug development? An interview with Lucy Donaldson

Alternative splicing: a new approach to drug development? An interview with Lucy Donaldson

RNA is becoming an interesting drug target as it takes possible intervention back one step to the synthesis of a target protein, instead of trying to block or inhibit a process. [More]
People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

People with disabilities, caregivers, veterans and healthcare professionals to attend 2016 Abilities Expo

Thousands of people with disabilities, their families, caregivers, seniors, wounded veterans and healthcare professionals are expected to attend Abilities Expo on February 5-7, 2016 at the Los Angeles Convention Center, West Hall A. Admission is free and the new show hours will get attendees home in time to watch the Super Bowl: Friday 11 am to 5 pm, Saturday 10 am to 6 pm and Sunday 10 am to 2 pm. [More]
Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai Inc. announced today that the U.S. Food and Drug Administration approved Halaven (eribulin mesylate) Injection (0.5 mg per mL) for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen. [More]
Zika virus threat across the Americas

Zika virus threat across the Americas

Yesterday, the World Health Organization (WHO) announced that the Zika virus outbreak in Brazil was “spreading explosively” in the Americas and that as many as four million people could be infected by the end of the year. [More]
Researchers develop new painkiller as strong as morphine but not addictive

Researchers develop new painkiller as strong as morphine but not addictive

Researchers at Tulane University and Southeast Louisiana Veterans Health Care System have developed a painkiller that is as strong as morphine but isn't likely to be addictive and with fewer side effects, according to a new study in the journal Neuropharmacology. [More]
New NYUCD study explores how gene expression initiated in notochord

New NYUCD study explores how gene expression initiated in notochord

A new study by basic science researchers in the Department of Basic Science and Craniofacial Biology at New York University College of Dentistry sought to understand how gene expression is initiated in the notochord, the evolutionary and developmental precursor of the backbone. [More]
AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. [More]
Halaven (eribulin mesylate) approved for treatment of liposarcoma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug. [More]
New technique may reduce need for amputation in patients with critical limb ischemia

New technique may reduce need for amputation in patients with critical limb ischemia

A new imaging technique could reduce the need for amputation in patients with critical limb ischemia, according to a study publised today in the scientific journal JACC. [More]
Advertisement
Advertisement